You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Stada and Xbrane receive approval for Ximluci

Stada and Xbrane have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has provided a marketing authorisation for Ximluci.